The Senate Committee on Health and Human Services approved legislation Tuesday targeting patients with terminal illness who want access to experimental drugs.
To access this content, you must purchase a Premium membership, or log in if you are a member.
Support Our Advertisers
STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.
Subscribe here for a FREE 14 day trial of our daily news roundup.